<?xml version="1.0"?>

<document>
	<title>IgA and IgG antibodies against surface antigens of Pseudomonas
   aeruginosa in sputum and serum from patients with cystic fibrosis.</title>

	<author>Schiotz-P-O.</author>
	<author>Hoiby-N.</author>
	<author>Permin-H.</author>
	<author>Wiik-A.</author>

	<source>Acta-Pathol-Microbiol-Scand [C]. 1979 Jun. 87C(3). P 229-33.</source>

	<abstract>Eleven cystic fibrosis (CF) patients chronically infected in the
   lungs with mucoid Pseudomonas aeruginosa and presenting multiple
   precipitins in serum against this bacterium (CF + P) and 10 CF
   patients without P. aeruginosa infection (CF-P) had their serum and
   sputum sol phase specimens examined for antibodies of the IgA and IgG
   classes against surface antigens of P. aeruginosa by means of an
   indirect immunofluorescence technique. Both the IgA and IgG antibody
   titres demonstrated in serum and sputum of the CF + P patients were
   significantly higher than in those of the CF-P patients (p less than
   0.01). The titre of IgA antibodies in the sputum was higher than in
   serum in 3 cases indicating local pulmonary production of specific
   IgA antibodies. The role of the demonstrated antibodies in the local
   pulmonary immune defense mechanisms and the possible patogenesis of
   the pulmonary tissue damage in CF patients is discussed.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>IGA</majorsubject>
	<majorsubject>IGG</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>
	<majorsubject>SPUTUM: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>ANTIBODIES-BACTERIAL</minorsubject>
	<minorsubject>ANTIGENS-BACTERIAL</minorsubject>
	<minorsubject>ANTIGENS-SURFACE</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHRONIC-DISEASE</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>FLUORESCENT-ANTIBODY-TECHNIC</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</minorsubject>
	<minorsubject>MALE</minorsubject>

	<reference>001   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975</reference>
	<reference>002   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971</reference>
	<reference>003   BJORNSON AB           J INFECT DIS SUPPL             130   119 974</reference>
	<reference>004   BJORNSON AB           J INFECT DIS SUPPL             130   127 974</reference>
	<reference>005   BOXERBAUM B           AM REV RESPIR DIS              108   777 973</reference>
	<reference>006   BROGAN TD             THORAX                          30    72 975</reference>
	<reference>007   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>008   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969</reference>
	<reference>009   GIBSON LE             PEDIATRICS                      23   545 959</reference>
	<reference>010   GOVAN JRW             J MED MICROBIOL                  8   513 975</reference>
	<reference>011   HANN S                INFECT IMMUN                    14   114 976</reference>
	<reference>012   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973</reference>
	<reference>013   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>014   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>015   HOIBY N               SCAND J IMMUNOL SUPPL 2          4   187 975</reference>
	<reference>016   HOIBY N               SCAND J RESPIR DIS              58    65 977</reference>
	<reference>017   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   107 977</reference>
	<reference>018   KOCH C                ACTA PATH MICROBIOL SCAND (C)   83   144 975</reference>
	<reference>019   MCFARLANE H           BR MED J                         1   423 975</reference>
	<reference>020   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975</reference>
	<reference>021   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   85    57 977</reference>
	<reference>022   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978</reference>
	<reference>023   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87     1 979</reference>
	<reference>024   WIIK A                IMMUNOLOGY                      23    53 972</reference>
	<reference>025   YOUNG LS              J INFECT DIS SUPPL             130   111 974</reference>

	<citation>1   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   88   275 980</citation>
	<citation>2   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981</citation>
	<citation>3   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>4   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>5   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>6   SCHILLER NL           PEDIATR RES                     17   747 983</citation>
	<citation>7   DORING G              J INFECT DIS                   147   744 983</citation>
	<citation>8   KOHLER B              Z KLIN MED                      40  1773 985</citation>
	<citation>9   BALTIMORE RS          PEDIATR RES                     20  1085 986</citation>

</document>
